RNC Capital Management’s ResMed RMD Stock Holding History

RNC Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,166	Closed	-$320K	–	149
2023 Q3	$320K	Buy	2,166 +266	+14%	+$48.1K	0.02%	124
2023 Q2	$415K	Hold	1,900	–	–	0.02%	132
2023 Q1	$416K	Hold	1,900	–	–	0.02%	132
2022 Q4	$395K	Hold	1,900	–	–	0.02%	134
2022 Q3	$415K	Hold	1,900	–	–	0.03%	125
2022 Q2	$398K	Sell	1,900 -7	-0.4%	-$1.49K	0.02%	134
2022 Q1	$462K	Buy	1,907 +7	+0.4%	+$1.69K	0.02%	131
2021 Q4	$495K	Hold	1,900	–	–	0.02%	132
2021 Q3	$501K	Hold	1,900	–	–	0.03%	128
2021 Q2	$468K	Hold	1,900	–	–	0.02%	125
2021 Q1	$369K	Hold	1,900	–	–	0.02%	125
2020 Q4	$404K	Hold	1,900	–	–	0.03%	121
2020 Q3	$326K	Hold	1,900	–	–	0.02%	115
2020 Q2	$365K	Hold	1,900	–	–	0.03%	106
2020 Q1	$280K	Hold	1,900	–	–	0.02%	117
2019 Q4	$294K	Hold	1,900	–	–	0.02%	132
2019 Q3	$257K	Hold	1,900	–	–	0.02%	131
2019 Q2	$232K	Sell	1,900 -334	-15%	-$37K	0.02%	132
2019 Q1	$232K	Sell	2,234 -198	-8%	-$20.4K	0.02%	128
2018 Q4	$277K	Buy	2,432 +532	+28%	+$57K	0.02%	115
2018 Q3	$219K	Buy	+1,900	New	+$208K	0.01%	130

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

RNC Capital Management's RMD Position: Q4 2023 in Review

RNC Capital Management sold out of ResMed (RMD) in Q4 2023, closing a stake of 2,166 shares — an estimated $320K sold.

RNC Capital Management first reported a position in RMD in Q3 2018 and held it in 21 quarters. The position peaked at $501K in Q3 2021. 687 funds tracked by Wall St. Rank hold RMD as of Q4 2023.

RNC Capital Management reported no remaining ResMed position as of Q4 2023 after selling out during the quarter.
RNC Capital Management sold 2,166 ResMed shares in Q4 2023, an estimated $320K.
RNC Capital Management first reported a position in ResMed in Q3 2018 and held it in 21 quarters.
RNC Capital Management's ResMed position peaked at $501K in Q3 2021.
687 funds tracked by Wall St. Rank held ResMed as of Q4 2023.

Based on RNC Capital Management's 13F filing for Q4 2023, filed 17 Jan 2024.